Skip to main content
. 2003 Mar 26;138(6):1129–1139. doi: 10.1038/sj.bjp.0705085

Table 2.

Competition of agonists versus [3H]-NAD-199 binding to membranes of CHO cells expressing the human 5-HT1A receptor

Ligand DPAT 5-OH DPAT 6-OH DPAT 7-OH DPAT 8-OH DPAT
enantiomer R S R S R S R S R S
pKh±s.e.m. 8.22±0.05 7.74±0.19 6.53±0.23 7.48±0.18 6.32±0.09 7.04±0.36 7.45±0.13 6.84±0.20 9.26±0.12 9.76±0.33
(Kl(nM)) (6.0) (18) (280) (33) (480) (92) (35) (145) (0.55) (0.18)
pKl±s.e.m 6.09±0.01 5.96±0.03 5.07±0.13 5.54±0.13 4.61±0.12 5.22±0.06 5.57±0.04 5.42±0.09 7.24±0.05 7.81±0.10
(Kl(nM)) (813) (1109) (8433) (2884) (24320) (5984) (2685) (3784) (58) (15)
Rh±s.e.m % 51.0±4.0 49.1±4.5 51.4±12.1 38.6±7.9 40.6±3.5 21.6±5.2 53.3±0.8 47.5±5.8 44.7±7.4 38.4±4.6
n 3 3 3 4 8 3 4 4 6 4

The binding of a series of agonists was determined in competition versus [3H]-NAD-199 as described in the Methods section. Competition curves were fitted well by two-binding site models in all cases (P<0.05), and Kh, Kl and percentage higher affinity site (Rh) values (mean± s.e.m., n experiments) are recorded.